VOLUME 15 | NUMBER 6 | JUNE 2012 nature neurOSCIenCe a r t I C l e S Group I metabotropic glutamate receptors (mGluRs) are enriched at excitatory synapses in the brain, where they are important in neural plasticity 1 and behavioral responses including inflammatory pain, fear conditioning, drug addiction and schizophrenia [2] [3] [4] . Group I mGluRs localize primarily to the lateral margin of the postsynaptic membrane 5 , where they respond to glutamate as it diffuses from release sites in the central synaptic region 6 . Group I mGluRs evoke changes by modulating membrane ion channels 7 , intracellular ion channels 8 and signaling cascades including EF2 kinase 9 , MAP kinase 10 , mTORC1 (ref. 11) and endocannabinoid synthesis 12 . The coupling mechanisms for several of these outputs involve proteins of an adaptor protein family, termed Homer, that bind to a proline-rich sequence in the C terminus of group I mGluRs 13 . In an exemplar assay, Homer binding to group I mGluRs expressed in superior cervical ganglion neurons blocks coupling to M-type potassium channels and voltage sensitive Ca 2+ channels 7 . Homer binding to group I mGluRs also reduces agonist-independent activation of BK channels in granule cell neurons 14 .
a r t I C l e S Group I metabotropic glutamate receptors (mGluRs) are enriched at excitatory synapses in the brain, where they are important in neural plasticity 1 and behavioral responses including inflammatory pain, fear conditioning, drug addiction and schizophrenia [2] [3] [4] . Group I mGluRs localize primarily to the lateral margin of the postsynaptic membrane 5 , where they respond to glutamate as it diffuses from release sites in the central synaptic region 6 . Group I mGluRs evoke changes by modulating membrane ion channels 7 , intracellular ion channels 8 and signaling cascades including EF2 kinase 9 , MAP kinase 10 , mTORC1 (ref. 11) and endocannabinoid synthesis 12 . The coupling mechanisms for several of these outputs involve proteins of an adaptor protein family, termed Homer, that bind to a proline-rich sequence in the C terminus of group I mGluRs 13 . In an exemplar assay, Homer binding to group I mGluRs expressed in superior cervical ganglion neurons blocks coupling to M-type potassium channels and voltage sensitive Ca 2+ channels 7 . Homer binding to group I mGluRs also reduces agonist-independent activation of BK channels in granule cell neurons 14 .
The Homer binding site (TPPSPF) contains a consensus site for proline-directed kinases. Proline-directed kinases are activated by multiple neurotransmitter and growth factor receptors and are critical in the control of cellular processes including cell proliferation, differentiation, motility and neuronal plasticity 15 . The ability of Homer binding to modify mGluR signaling begs the question of whether proline-directed kinase-mediated phosphorylation of mGluR functions in receptor signaling.
Here we report that group I mGluR signaling is dynamically controlled by proline-directed kinases acting in concert with a multidomain scaffolding protein termed Preso1. Preso1 includes WW, PDZ and FERM domains, and it was previously reported to bind PSD95 (ref. 16 ) and to modulate dendritic spine morphogenesis. We identified Preso1 in a screen for proteins that bind Homer and determined that it also binds group I mGluR and proline-directed kinases including CDK5 and ERK. Preso1 enhances the ability of proline-directed kinases to bind mGluR and phosphorylate the Homer binding site in mGluR. This action of Preso1 appears analogous to that of A-kinase anchoring proteins (AKAPs) 17 to recruit PKA to phosphorylate its substrates. Preso1-dependent phosphorylation of mGluR enhances Homer binding and downregulates mGluR signaling in cellular assays. To assess this mechanism in vivo, we examined behavioral responses in a mouse model of inflammatory pain, which is dependent on sustained activation of group I mGluRs 3 . We confirmed that inflammatory pain depended on mGluR5 and was increased in mouse models that interrupt Homer binding to mGluR5, owing either to genetic deletion of Homer or to genetic knock-in of an mGluR5 point mutant that cannot bind Homer. Inflammatory pain was also increased in a Preso1 −/− mouse, and this was coupled to increased mGluR5 activity. These studies support a model in which Preso1 functions to facilitate a r t I C l e S proline-directed kinase modulation of Homer binding to mGluR and thereby controls the amplitude and duration of mGluR signaling.
RESULTS

Preso1 is a Homer-binding protein enriched in brain
We used the Homer1 EVH1 domain to perform a yeast two-hybrid screen of a rat brain cDNA library and identified a 1.2-kb fragment corresponding to the C terminus of KIAA0316. The full-length gene was cloned by 5′ and 3′ rapid amplification of cDNA ends (RACE) and determined to be homologous to human FRMPD4 (also termed PDZD10, PDZK10 and Preso 16 ) , and is here termed Preso1. The Preso1 protein contains several domains, including a Homer binding site (Fig. 1a) , and is conserved from Drosophila melanogaster to human (Supplementary Fig. 1 ). Public databases include two related genes that we term Preso2 (FRMPD3, KIAA1817) and Preso3 (FRMPD1 (ref. 18) , FRMD2, KIAA0967) (Supplementary Fig. 2 ). Mouse and human Preso1 and Preso2 are near each other on the X chromosome, whereas Preso3 is autosomal (human chromosome 9, mouse chromosome 4). mRNAs of all three Preso genes are expressed broadly in brain and spinal cord in mouse (Supplementary Fig. 3 ).
Hemagglutinin (HA)-tagged Homer1c (the brain-enriched Homer1 splice form) 19 immunoprecipitated with Preso1 (Fig. 1b) . This interaction was disrupted either by point mutation of the canonical polyproline-binding surface of the Homer1 EVH1 domain or by point mutation of the predicted Homer binding site in Preso1 (Preso1FR; Fig. 1b) . Thus, the Homer-Preso1 interaction involves conventional binding properties of Homer, and it seems to be direct. Preso2 encodes a conserved Homer binding site, and it immunoprecipitated with Homer1c from HEK293T cell lysates, whereas Preso3 lacks a conserved Homer binding site and did not coimmunoprecipitate (Supplementary Fig. 4a) .
To examine the association of Preso1 with Homer in vivo, we immunoprecipitated Preso1 from detergent lysates of rat cerebellum and confirmed that Homer3 was coimmunoprecipitated (Fig. 1c) . mGluR1 and components of its signaling complex, including Shank, PSD95 and the inositol-1,4,5-trisphosphate receptor (IP 3 R) also immunoprecipitated with Preso1 (Fig. 1c) . Preso1 immunoreactivity was enriched in cultured hippocampal neurons and showed a punctate distribution that colocalized with the excitatory synaptic marker PSD95, but not with the inhibitory synaptic marker glutamic acid decarboxylase (GAD65) (78.6 ± 4.8% of Preso1 colocalized with PSD95 (all values expressed as ± 95% confidence interval), whereas 9.6 ± 2.1% colocalized with GAD65; n = 17-20 dendrites in 7 or 8 neurons; Fig. 1d ). Preso1 immunoreactivity also colocalized with mGluR5 in the neurons (68.6 ± 5.1%; Fig. 1d ). To confirm that Preso1 is a synaptic protein, we performed immunogold electron microscopy in the hippocampus. Preso1-immunogold localized to the postsynaptic spine, especially in the PSD and subjacent cytoplasm, overlapping the distributions of Homer and group I mGluRs 5, 19 (Fig. 1e ).
Preso1 interacts with group I mGluRs via its FERM domain
We considered the possibility that Preso1 functions as a scaffolding protein for group I mGluRs. Consistent with brain coimmunoprecipitation data, Preso1 immunoprecipitated with mGluR5 from detergent lysates of HEK293T cells ( Fig. 2a and Supplementary Fig. 4b ). By contrast, Preso1 did not immunoprecipitate mGluR2 or mGluR4, which belong to group II and group III mGluRs ( Supplementary  Fig. 4c,d ). Preso1 possesses several protein interaction domains, and we examined whether Preso1 might directly interact with mGluR5 independent of Homer. Preso1 or deletion mutants were cotransfected with HA-tagged mGluR5 into HEK293T cells and npg a r t I C l e S assayed for interaction by coimmunoprecipitation. Preso1 antibody immunoprecipitated mGluR5 that was expressed with any of the N-terminal deletion mutants except Preso1-∆FERM (Fig. 2a) . Notably, point mutants of both Preso1 and mGluR5 that do not bind Homer (Preso1FR; mGluR5 F1128R (mGluR5FR)) retained interaction in the coimmunoprecipitation assay (Fig. 2a) , suggesting that Preso1 binding to mGluR5 does not depend on Homer. These data also suggest that the FERM domain is required for Preso1 binding to mGluR5. We confirmed that the isolated Preso1 FERM domain was sufficient to immunoprecipitate mGluR5 (Fig. 2b) . We next examined the region of mGluR5 required for interaction with Preso1 using coimmunoprecipitation assays with mGluR5 C-terminal mutants. Preso1 immunoprecipitated mGluR5 1-1020 , but not mGluR5 (Fig. 2c) . As the Homer binding site is at 1128, these data indicate that sequence element(s) in mGluR5 required for Preso1 binding are at least 100 amino acids remote from the Homer binding site (Fig. 2d) . mGluR5 920-1020 includes a predicted FERM domain binding site 20 and a D-domain implicated as a binding site for proline-directed kinases in other proteins 21 ( Fig. 2d) . Mutations of the putative FERM domain binding sites (mGluR5 Y965A V967A ) resulted in only a modest reduction of its immunoprecipitation with Preso1 (Fig. 2e) . However, the combined point mutations of the putative FERM-binding site and the Homer binding site (mGluR5 Y965A V967A F1128R ; mGluR5YVF) markedly reduced mGluR5 immunoprecipitation with Preso1 (Fig. 2e) . The dependence of mGluR5-Preso1 binding on the Homer binding site in mGluR5 is consistent with the notion that native Homer proteins in HEK293T cells 22 can link these proteins, and it suggests that Preso1 binding to mGluR involves contributions of both the FERM domain-binding site and the Homer binding site.
Preso1 regulates mGluR phosphorylation and signaling
Coexpression of Preso1 increased binding between Homer and mGluR5 (172.7 ± 29.4% of control, n = 6, P = 0.004; Fig. 3a) . As Homer binding can be increased by phosphorylation of mGluR5 at the Homer binding site 23 , we hypothesized that Preso1 might function to increase Homer binding by increasing mGluR5 phosphorylation. We developed a phospho-specific antibody to the Homer binding site of group I mGluR (Supplementary Fig. 4e) , and found that mGluR5 phosphorylation increased with Preso1 expression (198.2 ± 72.8% of control, n = 7; P = 0.04; Fig. 3a) . To exclude the possibility that Preso1 increases Homer-mGluR5 binding indirectly by means of the association of Preso1 with Homer, we confirmed Preso1's effect using a mutant (Preso1FR) that does not bind Homer (Fig. 1b) . Enhanced Homer binding is dependent on phosphorylation, as Preso1 did not enhance Homer binding to an mGluR mutant (mGluR5TSAA, containing TS to AA mutations at Homer binding site) that cannot be phosphorylated at the Homer site (mGluR5 wild type (WT): 183.7 ± 51.8% of control, n = 6; P = 0.03; mGluR5TSAA: 122.6 ± 49.1% of control, n = 6; P = 0.58; Fig. 3b ). These data suggest that mGluR5 phosphorylation at its Homer binding site mediates Preso1's effect of increasing Homer binding to mGluR5.
We next investigated whether Preso1 regulates group I mGluR function. In a cellular assay, group I mGluR coupling to voltagesensitive calcium channels in superior cervical ganglion neurons, which do not natively express any mGluRs 24 , was inhibited by Homer binding 7 and was similarly inhibited by Preso1 (mGluR1: 55 ± 6% in control, n = 15; 16 ± 8% in Preso1, n = 11; P = 0.0001; mGluR5: 38 ± 5% in control, n = 24; 22 ± 6% in Preso1, n = 22; P = 0.0004; Fig. 3c,d) . Experiments with mGluR5 mutants indicated that Preso1's action depended on Preso1 binding to mGluR5 (absent with mGluR5YVF), Homer binding to mGluR5 (absent with mGluR5FR) and phosphorylation of the Homer binding site in mGluR5 and mGluR1 (absent with mGluR5TSAA and mGluR1TSAA) (mGluR5YVF: 26 ± 10% in control, n = 7; 25 ± 6% in Preso1, n = 8, P = 0.90; mGluR5FR: 26 ± 10% in control, n = 7; 23 ± 10% in Preso1, n = 11, P = 0.66; mGluR5TSAA: 16 ± 10% in control, n = 9; 16 ± 6% in Preso1, n = 13, P = 0.98; mGluR1TSAA: 43 ± 12% in control, n = 14; 41 ± 16% in Preso1, n = 6, P = 0.88; Fig. 3d ). Preso1 action is specific for group I mGluR, as it did not alter the activity of mGluR2 (64 ± 4% mGluR5 920 1020 T P P S P F 1126 npg a r t I C l e S in control, n = 7; 57 ± 12% in Preso1, n = 5, P = 0.30; Fig. 3d) , consistent with the finding that Preso1 selectively bound group I mGluRs ( Supplementary Fig. 4b-d ).
Preso1 binds proline-directed kinases
Inspection of the Homer binding site of group I mGluR ( Fig. 2d) suggested that the serine phosphorylation is mediated by proline-directed kinases, such as CDK5 and ERK. We found that expression of CDK5 and p35 (CDK5/p35) or constitutively active MEK (MEK DD), which activates ERK, induced mGluR5 phosphorylation in HEK293T cells (CDK5/p35: 563 ± 98% of control, n = 6; P = 0.0008; MEK DD: 1,049 ± 345% of control, n = 6; P = 0.006; Fig. 4a ). In cultured neurons, native mGluR phosphorylation was significantly reduced by CDK5 inhibitor or MEK inhibitor (UO126: 57.4 ± 11% of untreated, n = 4; P = 0.007; purvalanol A: 65.8 ± 9.5% of untreated, n = 4; P = 0.02; Fig. 4b ). These data support a role for CDK5 and ERK in phosphorylation of group I mGluR at the Homer binding site.
We next hypothesized that Preso1 binds proline-directed kinases that phosphorylate group I mGluRs. Preso1 contains a predicted D-domain that is conserved among Preso family members and across species (Supplementary Figs. 1 and 2) . As predicted, Preso1 immunoprecipitated from HEK293T cells with proline-directed kinases CDK5 and ERK (Fig. 4c,d) . Additionally, Preso1 enhanced the association of ERK1 with mGluR5 in HEK293T cells (166.6 ± 40% of control, n = 5; P = 0.02; Fig. 4e ). Endogenous Preso1 immunoprecipitated with CDK5 and with ERK1 and/or ERK2 (ERK1/2) from mouse brain (Fig. 4f,g ), suggesting that Preso1 and proline-directed kinases are naturally associated in vivo.
Preso1 −/− mouse generation We generated a conditional Preso1 −/− by inserting loxP sites in flanking introns of exon 3, which encodes the PDZ domain (Supplementary Fig. 5a ). Preso1 was deleted in the germline by mating conditional knockout mice with CMV-cre mice. Preso1 −/− mice were identified by PCR (data not shown), and mutant Preso1 mRNA expression was confirmed by reverse transcription and PCR of cortex and cerebellum (Supplementary Fig. 5b ). Preso1 deletion was further verified by western blots of detergent lysates of Preso1 −/− brain (Supplementary Fig. 5c ) and cultured cortical neurons (Supplementary Fig. 5d ). Male and female Preso1 −/− mice were viable and fertile, and appear similar to WT mice in their postnatal growth. Expression of Homer1b/c, Homer2, Homer3, NR1, GluA1 and GluA2/3 was not altered in 6-week-old Preso1 −/− brain, and expression of mGluR5 was not different in cortex or spinal cord (Supplementary Fig. 5e) .
Consistent with the hypothesized function of Preso1, mGluR5 phosphorylation (pSer-mGluR) and mGluR5 immunoprecipitation with Homer was reduced in Preso1 −/− cortex and spinal cord compared those in to WT littermates (binding: 76 ± 3.3% of WT in cortex, n = 5; P = 0.002; 73.6 ± 8.7% of WT in spinal cord, n = 8; P = 0.03; phosphorylation: 57.5 ± 22.2% of WT in cortex, n = 5; P = 0.04; 79.1 ± 10.6% of WT in spinal cord, n = 5; P = 0.03; Fig. 5a ). Additionally, immunoprecipitation of ERK1/2 with mGluR5 was reduced in Preso1 −/− brain (64.4 ± 10.9% of WT, n = 5; P = 0.04; Fig. 5b ).
Preso1 is required for dynamic Homer-mGluR5 binding
We examined the hypothesis that Preso1 is required for activitydependent phosphorylation of mGluR5 and enhanced Homer binding. In WT neurons, the group I mGluR agonist 3,5-dihydroxyphenylglycine (DHPG) resulted in an increase of mGluR5 phosphorylation and Homer binding to mGluR5 after 30 min (binding: 157 ± 33.8% of untreated, n = 5; P = 0.01; phosphorylation: 149 ± 36% of untreated, n = 5; P = 0.02; Fig. 5c ). By contrast, mGluR5 phosphorylation and Homer binding were reduced in Preso1 −/− neurons and were not Fig. 5c ). This is consistent with mGluR5 activation of CDK5 and ERK 25 , which then phosphorylate the receptor to mediate enhanced Homer binding in a receptor homologous feedback pathway. We also examined the effect of BDNF, which activates TrkB to increase ERK 26 , and found similar increases of mGluR5 phosphorylation and Homer binding in WT but not Preso1 −/− neurons (binding: 157.7 ± 14.5% in treated WT, n = 4; P = 0.001; 65.3 ± 18% in untreated Preso1 −/− , n = 4; P = 0.02; 69.8 ± 22.9% in treated Preso1 −/− , n = 4; P = 0.77; phosphorylation: 182.1 ± 15.1% of untreated, n = 5; P = 0.00002; 66.8 ± 9.5% in untreated Preso1 −/− , n = 4; P = 0.0002; 79.7 ± 8.3% in treated Preso1 −/− , n = 4; P = 0.09; Fig. 5c ). These observations suggest that Preso1 is required for dynamic regulation of mGluR5 phosphorylation and Homer binding in both homologous and heterologous receptor signaling pathways. Tamalin 27 , calcineurin inhibitor protein (CAIN) 28 and Norbin 29 bind group I mGluRs and modify signaling by changing expression of mGluR on the cell surface. mGluR5 expression on the surface of neurons in culture was not different between WT and Preso1 −/− (115.6 ± 21.6% of WT, n = 6; P = 0.14; Fig. 5d ). Furthermore, DHPG induced identical decreases of surface mGluR5 (65.4 ± 16.7% in WT, n = 4; P = 0.02; 65.2 ± 10.1% in Preso1 −/− , n = 3; P = 0.04; Fig. 5d ), suggesting that Preso1 does not function by regulating mGluR5 surface expression. This is consistent with the observed absence of an effect of Homer1 −/− Homer2 −/− Homer3 −/− genotype on mGluR5 surface expression 30 .
Pain response is increased in Preso1 −/− mice Formalin injection into the mouse hind paw results in an initial, transient behavioral pain response that is followed by a second, sustained response that is associated with tissue inflammation and is termed inflammatory pain 31 . This model is widely used in pain research, and group I mGluRs have been implicated in inflammatory pain by means of pharmacological agonists and antagonists 3 . To further validate the role of mGluR5, we examined Grm5 −/− mice and confirmed decreased pain responses in the second phase, but not in the first phase, after formalin injection compared with responses in their WT littermates ( Supplementary  Fig. 6a,b) . Furthermore, 2-methyl-6-(phenylethynyl)-pyridine (MPEP), an mGluR5 specific antagonist, substantially reduced the formalininduced inflammatory pain response in WT mice, but not in Grm5 −/− mice ( Supplementary Fig. 6a,b) . These results confirm a role for mGluR5 in formalin-induced inflammatory pain.
We next asked whether formalin-induced inflammatory pain is altered in Preso1 −/− mice. Preso1 −/− mice exhibited greater behavioral pain responses during the second phase, but not the first phase, compared with their WT littermates (first phase: 94.6 ± 24.2 s in WT, n = 9; 88 ± 25 s in Preso1 −/− , n = 8; P = 0.72; second phase: 347.6 ± 52.8 s in WT, n = 9; 576.3 ± 113.2 s in Preso1 −/− , n = 8; P = 0.002; Fig. 6a,b) . Notably, MPEP (30 mg per kilogram body weight, intraperitoneally) decreased pain responses during the second phase to the same degree in Preso1 −/− and WT mice (first phase: 68.7 ± 11.7 s in treated WT, n = 6; P = 0.13; 76.8 ± 24.7 s in treated Preso1 −/− , n = 6; P = 0.56; second phase: 207 ± 33.5 s in treated WT, n = 6; P = 0.002; 214.7 ± 47.3 s in treated Preso1 −/− , n = 6; P = 0.0002; Fig. 6a,b) . These data indicate that the increased inflammatory pain response in Preso1 −/− is mediated by mGluR5. Because ongoing sensory inputs contribute to formalin-induced pain 32 , we measured the excitability of dorsal root ganglion neurons from WT and Preso1 −/− mice and found similar excitabilities (Supplementary Fig. 7) . To assess the notion that Homer binding to mGluR5 is important to limit the intensity of the inflammatory pain response, we confirmed that inflammatory pain behavior was increased in Homer2 −/− Homer3 −/− mice, and in an mGluR5 mutant npg a r t I C l e S knock-in mouse in which Homer cannot bind the receptor (Grm5 R/R or mGluR5FR mice 33 ) (Supplementary Fig. 8a-d) . Furthermore, we found that inflammatory pain behavior was decreased in mice with selective deletion of the Homer1a isoform of the Homer1 gene (Homer1a −/− mice) 30 (Supplementary Fig. 8e,f ) , consistent with a mechanism whereby deletion of Homer1a increases Homer binding with mGluR5.
c-Fos expression is induced in neurons of the lumbar dorsal spinal cord by formalin injection into the hind paw, and it identifies neurons activated in the pain circuit that increase cellular [Ca 2+ ] 34 . We performed c-Fos immunostaining in lumbar level L4-L5 spinal cord from WT and Preso1 −/− mice after formalin injection and found more c-Fos positive neurons in the Preso1 −/− spinal cord than in WT spinal cord (lamina 1-2: 19.6 ± 2.7 in WT, n = 25; 26.6 ± 4.1 in Preso1 −/− , n = 22; P = 0.007; lamina 3-4: 6.1 ± 1.0 in WT, n = 25; 8.7 ± 2.1 in Preso1 −/− , n = 18; P = 0.03; lamina 5-6: 5.8 ± 1.1 in WT, n = 25; 11.1 ± 2.4 in Preso1 −/− , n = 18; P = 0.0001; Fig. 6c,d) . Furthermore, preinjection with MPEP reduced the number of c-Fos-positive neurons in the WT and Preso1 −/− spinal cord to the same degree (lamina 1-2: 14.9 ± 2.8 in treated WT, n = 18; P = 0.03; 13.6 ± 2.22 in treated Preso1 −/− , n = 18; P = 0.000009; lamina 3-4: 3.7 ± 0.7 in treated WT, n = 18; P = 0.001; 5.2 ± 0.8 in treated Preso1 −/− , n = 18; P = 0.009; lamina 5-6: 6.2 ± 1.2 in treated WT, n = 18; P = 0.62; 7.8 ± 1.2 in treated Preso1 −/− , n = 18; P = 0.03; Fig. 6c,d) . These findings corroborate behavioral pain assays and suggest that Preso1 −/− increases the number of neurons in the spinal cord pain pathway that reach a critical level of [Ca 2+ ] for c-Fos induction, through a mGluR5-dependent mechanism.
We also tested pain responses in the complete Freund's adjuvant (CFA) chronic pain model. Preso1 −/− mice were not different from WT littermates in their basal thermal pain responses, and they showed an identical initial pain response (WT: 13.6 ± 2.2 s, n = 9; Preso1 −/− : 13.6 ± 3.3 s, n = 9; P = 0.96; Fig. 6e) . However, Preso1 −/− mice exhibited increased thermal pain responses beginning 3 d after CFA injection and persisting through 5 d (day 1: 6.9 ± 2.1 s in WT, n = 9; 6.6 ± 2.6 s in Preso1 −/− , n = 9; P = 0.83; day 2: 10.2 ± 5.0 s in WT, n = 9; 7.3 ± 5.5 s in Preso1 −/− , n = 9; P = 0.26; day 3: 11.7 ± 3.6 s in WT, n = 9; 7.5 ± 3.3 s in Preso1 −/− , n = 9; P = 0.02; day 4: 11.1 ± 2.9 s in WT, n = 9; 2.6 ± 2.4 s in Preso1 −/− , n = 9; P = 0.03; day 5: 13.6 ± 4.2 s in WT, n = 9; 9.9 ± 2.2 s in Preso1 −/− , n = 9; P = 0.03; Fig. 6e ).
Enhanced mGluR-mediated Ca 2+ response in Preso1 −/− neurons Preso1 is expressed in the dorsal spinal cord (Supplementary Fig. 3 ) with an expression pattern similar to mGluR5 35 . On the basis of the increased behavioral pain and c-Fos expression in spinal cord of Preso1 −/− mice, we predicted that group I mGluR function would be enhanced in Preso1 −/− dorsal spinal cord neurons. We cultured these neurons from WT and Preso1 −/− mice and performed calcium imaging assays. Glutamate (100 µM) combined with APV (100 µM), an NMDA receptor blocker, and NBQX (100 µM), an AMPA receptor blocker, were used to stimulate mGluR. This cocktail was found to be more consistent than a selective agonist for mGluR5 (DHPG), as is consistent npg a r t I C l e S with the observation that mGluR1 signaling is enhanced by preceding depolarization 36 . Stimulation induced a rise of [Ca 2+ ] in both WT and Preso1 −/− neurons that persisted until washout (Fig. 7a) . The calcium response in Preso1 −/− neurons was significantly greater than that in WT neurons (WT: 3.28 ± 0.33 fold increase over basal Ca 2+ , n = 90; Preso1 −/− : 4.47 ± 0.44 fold increase over basal Ca 2+ , n = 74; P = 0.00003; Fig. 7a ). Pretreatment with MPEP (10 µM) and with Bay36-7620 (20 µM), an mGluR1 antagonist, blocked the sustained calcium response (Fig. 7a) , confirming that it is dependent on group I mGluR. We next asked whether the enhanced mGluR-mediated calcium response in Preso1 −/− spinal cord neurons would be rescued by expressing a Preso1 transgene. GFP or GFP-Preso1 constructs were electroporated into dorsal spinal cord neurons from Preso1 −/− mice on the day of culture initiation and used for calcium imaging after 2 d. GFP-Preso1-expressing neurons showed a markedly reduced mGluR-mediated calcium response compared to GFP expressing neurons (GFP: 2.38 ± 0.36 fold increase over basal Ca 2+ , n = 23; GFP-Preso1: 0.46 ± 0.35 fold increase over basal Ca 2+ , n = 19; P = 5 × 10 −9 ; Fig. 7b ), indicating that increased Ca 2+ responses in Preso1 −/− neurons can be reversed by Preso1.
Our model predicts that Preso1 facilitates proline-directed kinases to increase mGluR phosphorylation at the Homer binding site, and inhibits sustained mGluR responses (Fig. 4) . Accordingly, we asked whether the mGluR-dependent Ca 2+ response in spinal cord neurons is altered by proline-directed kinase inhibitors. We observed that the Ca 2+ response to sustained treatment with glutamate, APV and NBQX decreased over an interval of 2-9 min in most neurons, but [Ca 2+ ] again increased until washout in some neurons (Fig. 7c) . The percentage of neurons with Ca 2+ rise was significantly higher in Preso1 −/− than that in WT (WT: 11.5 ± 4.3%, n = 390; Preso1 −/− : 22.3 ± 7.4%, npg a r t I C l e S n = 360; P = 0.03; Fig. 7c) . The reversal by washout and subsequent cell viability assessed by Nomarski microscopy indicated that the delayed response was not due to cell death. Addition of UO126 (4 µM), or purvalanol A (5 µM) 2 min after onset of stimulation resulted in a two-to threefold increase of the percentage of neurons exhibiting a delayed rise of [Ca 2+ ] (UO126: 28.3 ± 5.7%, n = 420; P = 0.0004; purvalanol A: 23.8 ± 5.6%, n = 330; P = 0.005; Fig. 7c ). By contrast, kinase inhibitors did not change the percentage of Preso1 −/− spinal cord neurons showing this delayed response (UO126: 27.6 ± 6.6%, n = 270; P = 0.32; purvalanol A: 25.0 ± 5.3%, n = 190; P = 0.60; Fig. 7c ).
Although kinase inhibitors are likely to alter multiple signaling pathways, their acute action in blocking mGluR-dependent increases of [Ca 2+ ] is consistent with our model of Preso1 function.
DISCUSSION
The present study indicates that Preso1 functions as an essential part of the group I mGluR signaling complex, and supports its role as an anchoring protein for proline-directed kinases that mediate activitydependent, negative regulation of mGluR. The Preso1-prolinedirected kinase-Homer mechanism is highly dynamic, and findings support a consistent model across biochemical and behavioral phenotypes in several genetic models that modify Homer expression or Homer binding to mGluR. This mechanism is distinct from the canonical mechanism of GPCR desensitization mediated by G proteincoupled receptor kinases and β-arrestin pathway 37 in several ways. First, Preso1 and dynamic Homer binding do not influence the level of surface mGluR expression either in steady state conditions or after activation of the mGluR receptor. Inhibition of mGluR signaling appears to result as a direct consequence of Homer binding rather than of removal from the plasma membrane. Second, the prolinedirected kinases that mediate this response are not specific for the receptor, but rather are activated by many signaling pathways. This affords the possibility of receptor crosstalk, but it also highlights the importance of an anchoring protein for mGluR that can confer specificity to broad-substrate proline-directed kinases and thereby mimic the intrinsic specificity of G protein-coupled receptor kinases. Group I mGluRs reportedly desensitize in response to G protein-coupled receptor kinases 38 , but the natural relevance of the suggested pathways remains unknown. The Preso1 mechanism is distinct from other proteins that bind group I mGluR and modify signaling by changing expression of mGluR on the cell surface, including Tamalin 27 , calcineurin inhibitor protein (CAIN) 28 and Norbin 29 . Preso1 appears to limit the amplitude and duration of mGluR5 activation that underlies inflammatory pain in the formalin model and chronic pain in the CFA model. Preso1-dependent inhibition of mGluR5 may occur normally as part of a homologous receptor downregulation due to increased mGluR5 activation by glutamate, or as a heterologous receptor response due to increased proline-directed kinase activation by receptors such as TrkB 26 or the bradykinin receptor 39 . Phosphorylated ERK is upregulated during inflammatory pain and has been implicated as a mediator of neuronal excitability due to phosphorylation of a potassium channel 40 . CDK5 expression and activity is also elevated during inflammation and regulates pain signaling 41 . Previous studies have demonstrated that group I mGluR signaling becomes agonist independent if Homer does not bind and crosslink the receptor 14 . This mechanism underlies the effect of Homer1a in driving homeostatic scaling of AMPA receptors 30 and has been suggested to contribute to stress effects in fear conditioning 42 . Accordingly, agonistindependent mGluR5 signaling may contribute to inflammatory pain. Pain induced by inflammation also causes central sensitization and hypersensitivity 43 , and recent studies suggest a special role for the amygdala 44 . Hence, it is possible that Preso1 also contributes to central sensitization through regulation of mGluR function.
Group I mGluRs are important targets for therapies of cognitive diseases including fragile X mental retardation syndrome 45 and Alzheimer's disease 5 , and are notable for the ability of pharmacological agents to differentially alter signaling outputs (biased ligands) 46 . It is possible that Preso1 contributes to this distinctive pharmacology. Although Preso1 and Homer binding uniformly inhibited the responses of group I mGluRs monitored here, group I mGluRs signal in several output pathways (see introduction), and Homer binding to mGluR5 does not uniformly inhibit all outputs. For example, mGluR1 coupling to intracellular IP 3 receptors is increased by Homer crosslinking 47 . Accordingly, the effect of Preso1 on the signaling of group I mGluRs could be output specific.
The yeast protein STE5 provides a precedent for a proline-directed kinase anchoring protein 48 , but Preso1 appears to be the first example of a proline-directed kinase anchoring protein for higher organisms. This action is similar to that of AKAPs, which coordinate signal transduction complexes by recruiting multiple signaling enzymes near potential substrates, including G protein-coupled receptors 49 . Consistent with the notion that Preso1 functions as an anchoring protein, Preso1 includes domains that can interact with the cytoskeleton, including the Rac-activation domain, and has been reported to interact with β-Pix 16 . Many GPCRs encode predicted FERM domain binding sites and D-domains (GPCR databases; http://www.gpcr.org/ 7tm/), suggesting that Preso family members may have a broader role in GPCR signaling. However, only group I mGluRs contain a Homer binding site that is also a consensus for proline-directed kinases, which predicts that Presos uniquely coordinate dynamic changes of Homer binding to group I mGluR. Preso2 and Preso3 mRNAs are broadly expressed in the nervous system, but they have not been examined for their role in regulating GPCR signaling. Presos are also expressed outside of the central nervous system 18 , and they will be important for a comprehensive understanding of GPCR signaling.
METHODS
Methods and any associated references are available in the online version of the paper. 7.36 using KOH and osmolarity adjusted to 300 mOsm with sucrose. In current clamp recordings, action potential measurements were performed with an Axon 700B amplifier and the pCLAMP 9.2 software package (Axon Instruments). All experiments were performed at room temperature (~25 °C).
Behavioral assays. Inflammatory pain responsiveness was assessed using formalin, as described 52 . Mice were injected subcutaneously with formalin (10 µl, 5% in saline) into the dorsal side of one hind paw. The total time spent licking or biting the injected hind paw was recorded during each 5-min interval for 60 min. For pharmacologic studies, MPEP (30 mg/kg in 10% Tween-80; Tocris) was administered subcutaneously 20 min before formalin injection.
CFA-induced pain response was performed as described 53 . Briefly, the intraplantar region of one hind paw of each mouse was injected with 6 µl 50% CFA solution in saline. Thermal-pain sensitivity was assessed by recording paw withdrawal latency on exposure to a defined radiant-heat stimulus (Hargreaves test) before CFA injection and 1-5 d after injection.
Statistical analysis. All data were analyzed by two-tailed Student's t-test except the behavior data, which were analyzed by one-way ANOVA. Values are presented as means ± 95% confidence interval.
